New method for detecting H. pylori and its mutations can help dyspeptic patients in resource poor remote settings: PIB
Infections with H. pylori affect over 43 percent of the world’s population with a wide range of gastrointestinal disorders
Infections with H. pylori affect over 43 percent of the world’s population with a wide range of gastrointestinal disorders
Vonoprazan is used in the treatment of disorders related to Gastroesophageal Reflux Disease (GERD)
Launches Opentop 40, Opentop D, Opentop L, Opentop Dsr and Cefix 200 which are available for sale
Cyclosporine Ophthalmic Nanoemulsion is a preservative-free Nanoemulsion that has been approved in South Korea, Peru and several countries in the Middle East for treatment of dry eye syndrome
Strides’ approval for this product marks the 1st Indian approval from the USFDA for this complex formulation
Ofloxacin Ophthalmic Solution USP 0.3% is indicated for treatment of eye infections caused during the conditions of conjunctivitis and corneal ulcers
Short-term treatment of heartburn and other symptoms associated with gastroesophageal reflux disease (GERD)
This product is bioequivalent to the reference listed drug (RLD), Nexium 24 HR Delayed- Release Capsules, 2.0mg (OTC), of AstraZeneca Pharmaceuticals
Moist wound dressing for chronic wound treatment now available in Germany
Diclofenac Sodium and Misoprostol Delayed Release Tablets USP, 50mg/200 mcg and 75mg/200 mcg had annual sales of USD 13 mn in the United States
Subscribe To Our Newsletter & Stay Updated